Medical News Update
- Drugs
- CDERLearn Training and Education
- What's New Related to Drugs
- Competitive Generic Therapy Approvals
- Positron Emission Tomography: Product Quality Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations - 11/13/2023
- Recently Issued Guidance Documents
- Meta Herbal Issues Voluntary Nationwide Recall of Magnum XXL 9800 Capsules Due to Presence of Undeclared Sildenafil
- Frequently Requested or Proactively Posted Compliance Records
- Antimicrobial Resistance Information from FDA
- Compounding: Inspections, Recalls, and other Actions
- FDA warns consumers of hidden drug ingredients in Dr. Ergin’s SugarMD Advanced Glucose Support
- Generic Drug Facilities, Sites and Organization Lists
- Drug Trials Snapshots
- Novel Drug Approvals for 2022
- Drug Trials Snapshots: IMJUDO
- Computational Simulations Shed Light on Factors Affecting Nasal Spray Distribution
- Drug Trials Snapshots: ENJAYMO
- Expanded Access | Information for Physicians
- SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin
- FDA CDER and CBER & Duke-Margolis Center for Health Policy | Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development - 06/07/2023